Neyssa M. Marina

机构：Arcus Biosciences (United States) · ORCID：0000-0002-7195-8887

发表论文 294 篇 · 总被引 18191 次 · h-index 65

代表论文

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort (2019 · European Journal of Cancer · 被引 750)
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial (2016 · The Lancet Oncology · 被引 561)
Genome-Informed Targeted Therapy for Osteosarcoma (2018 · Cancer Discovery · 被引 485)
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008 (2019 · Journal of Clinical Oncology · 被引 151)
Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma (2020 · Journal of Clinical Oncology · 被引 111)
Longitudinal follow‐up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study (2017 · Cancer · 被引 79)